Botanical species · safety record

Liriope muscari

The EFSA Compendium of Botanicals holds 7 constituent measurements for Liriope muscari. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Liriope muscari (Decne.) L.H.Bailey

7Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Steroidal saponins2
  • Emodin1
  • Furanocoumarins1
  • Indole alkaloids1
  • Steroidal glycosides1
  • Syringaresinol1

Plant parts

  • Roots and other underground parts7

Preparations

  • Solvent extraction7

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
FuranocoumarinsRoots and other underground partsSolvent extractionHPLC with standard detection methodsResolve DOI
Indole alkaloidsRoots and other underground partsSolvent extractionHPLC with standard detection methodsResolve DOI
Steroidal glycosidesRoots and other underground partsSolvent extractionUHPLC-MS-MSResolve DOI
Steroidal saponinsRoots and other underground partsSolvent extractionHPLC-ELSDResolve DOI
Steroidal saponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SyringaresinolRoots and other underground partsSolvent extractionHPLC with standard detection methodsResolve DOI
EmodinRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Tsai, Yu-Chi., Chiang, Shang-Yu., El-Shazly, Mohamed., Wu, Chin-Chung., Beerhues, Ludger., Lai, Wan-Chun., Wu, Shou-Fang., Yen, Ming-Hong., Wu, Yang-Chang., Chang, Fang-Rong. The oestrogenic and anti-platelet activities of dihydrobenzofuroisocoumarins and homoisoflavonoids from Liriope platyphylla roots . Food chemistry, 2013, vol. 140, no. 1-2, p. 305-314. DOI
  2. Wu, Yan., Li, Yong-wei., Qi, Jin., Yu, Bo-yang. Ethyl acetate-soluble chemical constituents of fibrous roots of Liriope muscari. Zhongguo shiyan fangjixue zazhi, 2014, p. 40-43.
  3. Choi, Soo-Jung., Choi, Janggyoo., Jeon, Heejin., Bae, Soo Kyung., Ko, Jaeyoung., Kim, Jinwoong., Yoon, Kee Dong. Application of high-performance countercurrent chromatography for the isolation of steroidal saponins from Liriope plathyphylla . Journal of separation science, 2015, vol. 38, no. 1, p. 18-24. DOI
  4. Ma, Shengtang., Kou, Junping., Yu, Boyang. Safety evaluation of steroidal saponin DT-13 isolated from the tuber of Liriope muscari (Decne.) Baily . Food and chemical toxicology, 2011, vol. 49, no. 9, p. 2243-2251. DOI
  5. Li, Yong-Wei., Qi, Jin., Wen-Zhang., Zhou, Shui-Ping., Yan-Wu., Yu, Bo-Yang. Determination and Fingerprint Analysis of Steroidal Saponins in roots of Liriope muscari (Decne.) L. H. Bailey by ultra high performance liquid chromatography coupled with ion trap time-of-flight mass spectrometry . Journal of separation science, 2014, vol. 37, no. 14, p. 1762-1772. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue